SOAT1 and neoplasm: Urokinase-type fibrinogen activator receptor (uPAR) and tissue proteinase B can interfere with the JAK-STAT pathway-dependent expression of VEGF, thereby inhibiting tumor-induced angiogenesis (Miyatake et al., 2013).